Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays

BACKGROUND: Patients with severe hemophilia A and inhibitors are at risk of bleeding during invasive procedures. The standard of care for preventing perioperative bleeding has been replacement therapy with FVIII concentrates or for patients with high-titer inhibitors, bypassing agents. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizilocak, Hande, Yukhtman, Clara Lana, Marquez-Casas, Elizabeth, Lee, Jeanie, Donkin, Jennifer, Young, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598318/
https://www.ncbi.nlm.nih.gov/pubmed/31275538
http://dx.doi.org/10.1177/2040620719860025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598318/
https://www.ncbi.nlm.nih.gov/pubmed/31275538
http://dx.doi.org/10.1177/2040620719860025

Ejemplares similares